Your browser doesn't support javascript.
loading
Characterization of Typhoid Intestinal Perforation in Africa: Results From the Severe Typhoid Fever Surveillance in Africa Program.
Birkhold, Megan; Datta, Shrimati; Pak, Gi Deok; Im, Justin; Ogundoyin, Olakayode O; Olulana, Dare I; Lawal, Taiwo A; Afuwape, Oludolapo O; Kehinde, Aderemi; Phoba, Marie-France; Nkoji, Gaëlle; Aseffa, Abraham; Teferi, Mekonnen; Yeshitela, Biruk; Popoola, Oluwafemi; Owusu, Michael; Nana, Lady Rosny Wandji; Cakpo, Enoch G; Ouedraogo, Moussa; Ouangre, Edgar; Ouedraogo, Isso; Heroes, Anne-Sophie; Jacobs, Jan; Mogeni, Ondari D; Haselbeck, Andrea; Sukri, Leah; Neuzil, Kathleen M; Metila, Octavie Lunguya; Owusu-Dabo, Ellis; Adu-Sarkodie, Yaw; Bassiahi, Abdramane Soura; Rakotozandrindrainy, Raphaël; Okeke, Iruka N; Zellweger, Raphaël M; Marks, Florian.
  • Birkhold M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Datta S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Pak GD; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea.
  • Im J; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea.
  • Ogundoyin OO; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria.
  • Olulana DI; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria.
  • Lawal TA; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria.
  • Afuwape OO; Division of Gastrointestinal Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria.
  • Kehinde A; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Phoba MF; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo.
  • Nkoji G; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo.
  • Aseffa A; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
  • Teferi M; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
  • Yeshitela B; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
  • Popoola O; Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Owusu M; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Nana LRW; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso.
  • Cakpo EG; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso.
  • Ouedraogo M; Laboratorie d'Analyses Medicales, Hopital Protestant Schiphra, Ouagadougou, Burkina Faso.
  • Ouangre E; Service de Chirurgie Viscérale, Hopital Yalgado, Ouagadougou, Burkina Faso.
  • Ouedraogo I; Pediatric Department, Hopital Charles de Gaulle, Ouagadougou, Burkina Faso.
  • Heroes AS; Department of Tropical Bacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
  • Jacobs J; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Mogeni OD; Department of Tropical Bacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
  • Haselbeck A; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Sukri L; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea.
  • Neuzil KM; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea.
  • Metila OL; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Owusu-Dabo E; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Adu-Sarkodie Y; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo.
  • Bassiahi AS; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Rakotozandrindrainy R; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Okeke IN; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Zellweger RM; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso.
  • Marks F; Department of Microbiology and Parasitology, University of Antananarivo, Antananarivo, Madagascar.
Open Forum Infect Dis ; 10(Suppl 1): S67-S73, 2023 May.
Article en En | MEDLINE | ID: mdl-37274524
Background: Typhoid intestinal perforation (TIP) remains the most serious complication of typhoid fever. In many countries, the diagnosis of TIP relies on intraoperative identification, as blood culture and pathology capacity remain limited. As a result, many cases of TIP may not be reported as typhoid. This study demonstrates the burden of TIP in sites in Burkina Faso, Democratic Republic of Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria. Methods: Patients with clinical suspicion of nontraumatic intestinal perforation were enrolled and demographic details, clinical findings, surgical records, blood cultures, tissue biopsies, and peritoneal fluid were collected. Participants were then classified as having confirmed TIP, probable TIP, possible TIP, or clinical intestinal perforation based on surgical descriptions and cultures. Results: A total of 608 participants were investigated for nontraumatic intestinal perforation; 214 (35%) participants had surgically-confirmed TIP and 33 participants (5%) had culture-confirmed typhoid. The overall proportion of blood or surgical site Salmonella enterica subspecies enterica serovar Typhi positivity in surgically verified TIP cases was 10.3%. TIP was high in children aged 5-14 years in DRC, Ghana, and Nigeria. We provide evidence for correlation between monthly case counts of S. Typhi and the occurrence of intestinal perforation. Conclusions: Low S. Typhi culture positivity rates, as well as a lack of blood and tissue culture capability in many regions where typhoid remains endemic, significantly underestimate the true burden of typhoid fever. The occurrence of TIP may indicate underlying typhoid burden, particularly in countries with limited culture capability.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Año: 2023 Tipo del documento: Article